Rheumatoid Arthritis Drugs Market Is Poised To Reach $30.4 Billion By 2025: Grand View Research, Inc.

The global Rheumatoid Arthritis Therapeutics Market size is expected to reach USD 30.4 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.6% during the forecast period. Some of the key trends driving the market are availability of novel biologics, increase in potential clinical pipeline candidates, and rise in aging population. Thus, growing availability and awareness of safer drugs are projected to escalate rheumatoid arthritis drugs market growth. 

Rheumatoid arthritis affects approximately 1% of the global population. The condition has different symptoms such as joint pain, swelling, and stiffness, which are generally accompanied by chronic pain and inability to perform daily activities. Over a prolonged period, this disorder can hamper a patient’s mobility and can lead to permanent joint damage. If left untreated, this disorder can lead to mobility impairment and risk of joint replacement.

Growing prevalence of the disease, presence of biologics & biosimilars, and well-defined regulatory guidelines are poised to provide a fillip to the market. According to the Arthritis Foundation, 64% of the population within the age group of 65 is likely to suffer from arthritis in U.S. Increasing awareness regarding disease remittance therapies and rising healthcare expenditure in developed regions are estimated to promote revenue growth.

Current treatment for rheumatoid arthritis includes generic pharmaceuticals such as NSAIDs and corticosteroids along with novel biologics such as JAK inhibitors and IL-6 antagonists, which are widely used in developed countries due to their high effectiveness. New product launches such as Infliximab and Adalimumab biosimilars are anticipated to work in favor of the market. Moreover, Eli Lilly’s Olumiant and AbbVie’s Upadacitinib are expected to cut down chances of disease remittance.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/rheumatoid-arthritis-therapeutics-market

Further key findings from the report suggest:

• North America held 56.6% of the market in 2016 due to rising awareness regarding disease treatment, growing geriatric population, and high adoption of biopharmaceuticals for treatment
• Due to growing popularity, the biopharmaceuticals segment is projected to exhibit a CAGR of 8.3% during the forecast period
• Prescriptions are anticipated to emerge as more reliable and a preferred sales channel over the same period
• Asia Pacific is the most promising region, registering a CAGR of 9.5% between 2017 and 2025
• Some of the key players in rheumatoid arthritis market are AbbVie; Boehringer Ingelheim GmbH; Novartis AG; Regeneron Pharmaceuticals, Inc.; Pfizer, Inc.; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd.; UCB S.A.; Johnson & Johnson Services, Inc.; and Amgen, Inc.

Grand View Research has segmented the rheumatoid arthritis drugs/therapeutics market on the basis of molecule types, sales channels, and region:

Rheumatoid Arthritis Therapeutics Molecule Outlook (Revenue, USD Million, 2014 - 2025)

• Pharmaceuticals
  • NSAIDs
  • Analgesics
  • DMARDs
  • Glucocorticoids
• Biopharmaceuticals
  • Biologics
    • TNF-α antagonists
    • T-cell inhibitors
    • CD20 antigen
    • JAK inhibitors
    • anti-IL6 biologics
  • Biosimilars
    • CD20 antigen
    • TNF-α antagonists

Rheumatoid Arthritis Therapeutics Sales Channel Outlook (Revenue, USD Million, 2014 - 2025)

• Prescription
• Over-the-Counter (OTC)

Rheumatoid Arthritis Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

Browse Full Press Release of This Report:  www.grandviewresearch.com/press-release/global-rheumatoid-arthritis-therapeutics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Masterbatch Market is Poised To Reach $15.81 Billion By 2025 | CAGR: 6.6%: Grand View Research, Inc.

The global Masterbatch Market is expected to reach USD 15.81 billion by 2025, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 6.6% primarily driven by increasing replacement of metal by plastic is projected to fuel the market growth. In addition, rising demand from the European region is further expected to propel the demand over the forecast period. 

In terms of revenue, color masterbatch was the largest segment in 2016 and the trend is anticipated to continue at a growth rate of 7.1% over the forecast period. Increasing need for improving the surface appearance of plastic components in automotive, building & construction, and consumer goods is expected to contribute to the growth. Additive masterbatch is being widely used on account of various properties it imparts to plastics such as antistatic, antifoaming, antioxidant, antimicrobial, thermo-stabilizer, barrier properties, metal deactivators, antiblock, flame retardant, UV stabilizer, oxygen scavenger, and abrasion resistance. The growth of packaging sector, especially plastic packaging, is anticipated to drive the masterbatch demand.

Masterbatch is used in various end-use industries, such as packaging, building & construction, consumer goods, automotive, agriculture, as it imparts useful functional properties such as smooth surface finish and desired hardness. The increasing spending capability of customers toward purchasing attractively packaged consumer goods is expected to trigger the need for various plastic components, which use masterbatches to improve the appearance and other properties. These factors together are anticipated to boost masterbatch market demand over the forecast period.

Access Full Research Report on Masterbatch Market:  www.grandviewresearch.com/industry-analysis/masterbatch-market

Further key findings from the report suggest:

• Color segment is expected to experience the fastest growth, in terms of value, at a CAGR of 7.1% from 2017 to 2025 as color masterbatch finds application in various end-use industries such as packaging, building & construction, consumer goods, automotive, and agriculture
• Polyethylene emerged as the largest carrier polymer segment, in terms of revenue, in 2016 and is estimated to be valued at USD 5,461.8 million by 2025. The growing popularity on account of useful properties of HDPE, LDPE, and LLDPE is projected to drive the growth.
• Packaging was estimated as the largest end-use industry due to different types of industrial, customer, and retail packaging segments across various geographies
• The U.S. masterbatch market, in terms of revenue, was valued at USD 1,624.3 million in 2016 and is estimated to reach USD 2,920.3 million by 2025. The consumer goods industry in the U.S. is projected to witness the fastest growth over the next eight years owing to the increasing demand from customers.
• Key players including A. Schulman, Inc., Ampacet Corporation, Cabot Corporation, Clariant AG, Plastiblends India Ltd., and Global Colors Group have a prominent presence in the global masterbatch market

Read More @ www.grandviewresearch.com/blogs/bulk-chemicals

Grand View Research has segmented the global masterbatch market on the basis of type, carrier polymer, end use, and region.

Masterbatch, Type Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2025)

• White
• Black
• Color
• Additive
• Filler

Masterbatch Carrier Polymer Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2025)

• Polypropylene (PP)
• Polyethylene (PE)
• Polyvinyl Chloride (PVC)
• Polyethylene Terephthalate (PET)
• Others

Masterbatch Market End Use Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2025)

• Packaging
• Building & Construction
• Consumer Goods
• Automotive
• Agriculture
• Others

Masterbatch Regional Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2025)

• North America
  • US.
• Europe
  • Germany
  • UK
  • France
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
  • Brazil
• Middle East & Africa

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-masterbatch-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Antifungal Drugs Market Is Expected To Jump Up $12.6 Billion By 2025: Grand View Research, Inc.

The global Antifungal Drugs Market was valued at USD 10.7 billion in 2015 and is expected to reach a value of USD 12.6 billion by 2025. The increasing incidence of fungal infections worldwide is the key contributing factor for the growth of the antifungal drugs market in the coming years. Rising adoption of immunosuppressive andantineoplastic agents, prosthetic devices and grafts, and broad-spectrum antibiotics have resulted in the increasing incidence of fungal infections in the recent years. 

The growing geriatric population prone to infectious diseases and higher prevalence of chronic conditions, including HIV and cancer, are further contributing toward the rising demand for antifungals to treat opportunistic fungal infections over the forecast period. The large demand for these fungistatic agents is due to the nature of fungal infections, which are difficult to diagnose, yielding high mortality and morbidity rates.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/antifungal-drugs-market

Further Key Findings from the Study Suggest:

• Echinocandins segment is anticipated to exhibit lucrative growth owing to their cell wall-specific fungicidal property coupled with their broad-spectrum activity against Aspergillusand Candida species without cross-resistance risks
• Candidiasis indication segment is anticipated to witness the fastest CAGR over the forecast period due to the increasing drug resistance of the Candida speciesto Azoles
• North America held the largest market share as of 2015, which is attributable to higher awareness levels pertaining to the treatment of fungal infection and presence of target diseases in the population
• Asia pacific is predicted to exhibit the fastest growth due to improving healthcare facilities coupled with rising government initiatives to create awareness of infectious diseases amongst the population
• The companies are focusing on the development of effective therapeutic agents for the treatment of systemic fungal infections in immune-compromised patients
• Numerous ongoing public-private partnership agreements in the pharmaceutical industry for the development of novel therapeutics is predicted to provide this market with lucrative growth opportunities
• For example, the public-private partnership, namely Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator is anticipated to provide USD 44 million in 2016 and around USD 350 million in the coming 5 years to boost the R&D pipeline
• The partners involved in this partnership are the U.S. Department of Health and Human Services, the Antimicrobial Resistance Centrein England, and Boston University School of Law

Grand View Research has segmented the antifungal drugs market by drug class, indication, and region:

Global Antifungal Drugs Class Outlook (Revenue, USD Million, 2014 - 2025)

• Azoles
• Echinocandins
• Polyenes
• Allylamines
• Others

Global Antifungal Drugs Indication Outlook (Revenue, USD Million, 2014 - 2025)

• Dermatophytosis
• Aspergillosis
• Candidiasis
• Others

Antifungal Drugs Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• The Middle East and Africa
  • South Africa

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-antifungal-drugs-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

PVD Faucet Finishes Market Is Going To Surpass $11.8 Billion By 2020 | CAGR 7.3%: Grand View Research, Inc.

The PVD Faucet Finishes Market size in U.S., Germany, and China is expected to value USD 11.8 billion by 2020, according to a new report by Grand View Research, Inc., exhibiting a 7.3% CAGR during the forecast period. Increasing expenditure on renovation by hotel groups and rise in home constructions are expected to drive demand for PVD faucet finishes. Increasing urbanization is another factor fueling market growth.

Physical Vapor Deposition (PVD) refers to the process of bonding a finish to a faucet. This process is preferred over powder coating, atomic layer deposition, and electroplating as faucets with PVD finishes offer resistance to scratches, wear and tear, and corrosion, and enhance durability. Several faucet manufacturing companies have been using this process in place of conventional electroplating processes.

North America and Europe are major travel destinations and the growing number of visitors is boosted the hotel and lodging industry in these regions. This, in turn, has fueled expenditure on building new hotels and rooms with advanced technologies and classic as well as unique interior fixtures. As a result, demand for different types of PVD faucet finishes is anticipated to be on the rise over the forecast period.

The global housing market is also expected to contribute significantly to the U.S., China, and Germany market for PVD faucet finishes. Rise in residential construction has led to demand for additional housing faucets, including bathroom and kitchen faucets and related fixtures and this is likely to fuel market growth in the coming years.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/physical-vapor-deposition-pvd-faucet-finishes-market

Further key findings from the report suggest:

• In 2016, China was estimated to be the largest market, followed by U.S. In China, the highest demand for faucets stemmed from the hotel industry, in terms of both volume and revenue. The industry constituted a share of 69.75% of the total market in terms of volume
• International multi-chain hotels are penetrating into tier-II and tier-III cities in China to capitalize on the growth potential created by expanding middle class population. This section of the society has been seeking premium hospitality services in the country in recent times  
• In U.S., the physical vapor deposition faucet finishes market was dominated by the residential homes segment, which is expected to increase from 9,302,992 faucets in 2016 to 10,598,304 faucets by 2020
• In Germany, physical vapor deposition faucet finishes are witnessing high demand in the home-use segment. The number of newly constructed homes is gradually increasing due to rising government support and easy availability of finances
• In terms of color variation, chrome faucets was the largest segment in 2016 and is expected to register a CAGR of 7.7% from 2017 - 2020
• Key players include Kohler Co.; Hansgrohe SE; GROHE AG; California Faucets, Inc.; Delta Faucet Company; American Faucets & Coatings Corporation; and Moen, Inc.

Grand View Research has segmented physical vapor deposition (PVD) faucet finishes market on the basis of color variation, application, and region.

PVD Faucet Finishes Color Variation Outlook (Volume, Number of Faucets; Revenue, USD Million, 2015 - 2020)

• Chrome
• Nickel
• Rose
• Black
• Gold

PVD Faucet Finishes Application Outlook (Volume, Number of Faucets; Revenue, USD Million, 2015 - 2020)

• Home Use
• Hotel Use

PVD Faucet Finishes Country Outlook (Volume, Number of Faucets; Revenue, USD Million, 2015 - 2020)

• US.
• Germany
• China

Access Press Release of this Report: www.grandviewresearch.com/press-release/physical-vapor-deposition-pvd-faucet-finishes-market-analysis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Animal Feed Antioxidants Market Is Set To Reach $256.9 Million By 2022: Grand View Research, Inc.

The global Animal Feed Antioxidants Market is expected to reach USD 256.9 Million by 2022, according to a new report by Grand View Research, Inc. Increasing importance of animal protein over plant-based counterparts is expected to play a crucial role in driving market growth. 

The government of China announced the “Guideline for Beef Industry Development Towards 2020” in September 2013, aimed at increasing domestic beef production capacity from 6.3 million tons in 2013 to 7.86 million tons by 2020. This move is expected to open new avenues for animal feed antioxidants market over the next seven years. 

Natural antioxidants reported revenue of over USD 80 million in 2014. Rising importance of tocopherols as a source of vitamin E in countries of European Union, particularly Germany and UK, amid regulatory support for its inclusion in feed industry will have a significant impact on natural product forms in the near future. 

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/animal-feed-antioxidants-market

 Further key findings from the report suggest:

• Global animal feed antioxidants demand was 58,202.9 tons in 2014 and is expected to grow at a CAGR of 3.7% from 2015 to 2022
• Demand for animal feed antioxidants was highest in poultry accounting for over 30% of the global volume share in 2014. Antioxidants are added to poultry feed to enhance the vitamin content and reduce the number of free radicals. Rising consumption of poultry products is expected to drive antioxidants market.
• Butylated Hydroxyanisole (BHA) was the majorly used synthetic antioxidant, accounting for over 13 kilo tons in 2014. It is used as a supplement in poultry on account of its property as a free radical scavenging agent.
• Animal feed antioxidants demand in aquaculture exceeded four kilo tons in 2014. Addition of antioxidants to feed helps in oxidizing fat in fish, which conserves vitamins and some nutritional content within the meat. Kemin Industries utilizes PARAdigmOX technology in formulation of its antioxidant product, Blue liquid, for aquaculture applications. The technology is based on ternary solvent system, which provides protection against oxidation in oil and interfaces of fish body.
• In July 2011, the government of Saudi Arabia announced a revised imported feed subsidy list comprising 31 feed ingredients including corn, soybean meal, and sorghum. Aforementioned subsidy allocation towards procurement of feed ingredients in Saudi Arabia is expected to open new opportunities for manufacturers to invest in the region.
• Global animal feed antioxidants industry was dominated by BASF, DSM, ADM, and Novozymes in 2014. These four companies accounted for over one-fourth of global volume of production in 2014. These market players have also integrated their business from raw material supply to manufacturing as well as distribution of antioxidants.

Grand View Research has segmented the global animal feed antioxidants market on the basis of livestock, product, and region:

Animal Feed Antioxidants Product Outlook (Volume Tons, Revenue, USD Million, 2012 - 2022)

• Natural
• Synthetic
  • Ethoxyquin
  • Butylated Hydroxyanisole (BHA)
  • Butylated Hydroxytoluene (BHT)

Animal Feed Antioxidants Livestock Outlook (Volume Tons, Revenue, USD Million, 2012 - 2022)

• Swine
• Poultry
• Cattle
• Aquaculture
• Others

Animal Feed Antioxidants Regional Outlook (Volume Tons, Revenue, USD Million, 2012 - 2022)

• North America
• Europe
• Asia Pacific
• RoW

Access Press Release of this Report: www.grandviewresearch.com/press-release/global-animal-feed-antioxidants-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

CRM Devices Market Is Poised To Reach $32.4 Billion By 2025 | CAGR: 7.8%

The global Cardiac Rhythm Management (CRM) Devices Market size is anticipated to reach USD 32.4 billion by 2025, according to a new report by Grand View Research, Inc., registering a 7.8% CAGR during the forecast period. Increase in demand for CRM devices can be attributed to supportive legislative policies by governments in developed and developing countries. Rising incidence of cardiovascular diseases (CVDs), supportive reimbursement scenario, and major advancements in technology are also anticipated to be key factors governing market growth.   

CRM devices serve as a permanent treatment option for patients suffering from arrhythmias. Innovation in Cardiac Resynchronization Therapy (CRT) devices is expected to drive this market. Additionally, there is an increase in the application of implantable cardioverter-defibrillators (ICDs) as they are now integrated with pacemakers, thus increasing the product’s life. Increase in demand for external defibrillators with growing in awareness and rising disease burden of sudden cardiac arrest (SCA) has also been observed. There is an expansion in the market for external defibrillators as governments in developed economies have been working on making countries more cardio-friendly.

According to statistics published by the Sudden Cardiac Arrest Foundation, about 6.0 million people within the U.S. region suffer from cardiac disorders, of which 0.8 million are affected by atrioventricular blockage, leading to cardiac failure. Such an alarming number leads to an increased cost of about USD 20-56 billion annually. CRM devices are being predominantly used to prevent surgical costs and readmission rates in hospitals, thereby propelling market growth.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/cardiac-rhythm-management-devices-industry

Further key findings from the study suggest:

• Defibrillators held a lucrative share in 2016 and are also likely to grow at a profitable rate over the forecast period due to increase in prevalence of CVDs. These devices are normally used as continuous monitoring devices for arrhythmias
• North America accounted for more than 35.0% of the overall market in 2016. This can be attributed to increasing incidence of cardiovascular diseases, supportive government policies, favorable reimbursement schemes available to patients, growing awareness, and rise in training programs
• Asia Pacific was observed to be the fastest growing market for CRM devices with a CAGR nearly 9.0%. This is owing to increasing awareness and accessibility of CRM devices
• Some of the key players operating in this space are St. Jude Medical; BIOTRONIK, Inc.; Medtronic; Boston Scientific Corporation; and ZOLL Medical Corporation.

Grand View Research has segmented the global CRM devices market on the basis of product and region:

CRM Devices Product Outlook (Revenue, USD Million, 2014 - 2025)

• Pacemakers
  • Implantable Pacemakers
  • External Pacemakers
• Defibrillators
  • Implantable Cardioverter Defibrillators (ICDs)
    • Subcutaneous ICD (S-ICD)
    • Transvenous ICD (T-ICD)
  • External Defibrillator (ED)
    • Manual ED
    • Automated ED (AED)
    • Wearable Cardioverter Defibrillator
  • Cardiac Resynchronization Therapy (CRT)
    • CRT-Defibrillators (CRT-D)
    • CRT-Pacemakers (CRT-P)

CRM Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa

Browse Full Press Release of This Report:  www.grandviewresearch.com/press-release/global-cardiac-rhythm-management-crm-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Laparotomy Sponge Market Is Estimated To Generate $1.4 Billion By 2025 | CAGR 7.6%

The global Laparotomy Sponge Market size is expected to reach USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 7.6% during the forecast period. Rising disease burden and subsequent improvement in treatment alternatives, growing geriatric population, and mounting number of cesarean deliveries are among key trends contributing to the growth of the market. Furthermore, R&D initiatives undertaken by leading players to improve counting and detection of sponges for prevent incidences of retained surgical items (RSI) are driving the market.

Number of abdominal surgeries performed every year is increasing tremendously owing to rise in prevalence of abdominal disorders. Cesarean section and cholecystectomy (removal of gall bladder) are among the top ten most commonly performed surgeries in U.S. Growing prevalence of cancer is leading to an upswing in laparotomy procedures for biopsies, which in turn is anticipated to provide a fillip to the market.

Moreover, development of technologically advanced sponge counting and detection systems is estimated to help the market gain significant traction over the coming years. For example, in June 2007, ClearCount Medical received FDA clearance for SmartSponge System. It was reportedly the world’s first RFID system for detection and counting of surgical towels and sponges to replace the manual counting method.

Various initiatives are being undertaken to reduce the incidence of RSI. A pediatric teaching hospital in Boston, Children’s Hospital Boston, conducted a quality improvement study for eliminating incorrect counts and count discrepancies. This study was focused on educating perioperative staff, reviewing prior count discrepancies, standardizing counting practice, and reviewing and revising the counting system for reducing RSI. This initiative resulted in reduction in RSI by 50% between 2009 and 2010.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/laparotomy-sponge-market

  

Further key findings from the report suggest: 

• The global laparotomy sponges market size was estimated at USD 713.5 millionin 2016 and is poised to expand at a CAGR of 7.6% from 2017 to 2025
• The radiopaque segment will maintain dominance in the market throughout the forecast horizon. The RFID segment is projected to witness the fastest CAGR of 8.1% during the same period
• Hospitals accounted for the largest revenue share of around 65.0% in 2016. This can be attributed increasing number of open abdominal surgeries performed in hospitals
• Asia Pacific emerged as the most promising regional market, registering a CAGR of 8.9% during the forecast period. Rising awareness regarding laparotomy is supplementing the growth of the region
• Themarket is highly fragmented in nature with presence of participants such as Medtronic; Derma Sciences, Inc.; Medical Action Industries, Inc.; Medline Industries, Inc.; Stryker; Premier Enterprises; ACTIMED; A Plus International, Inc.; Cardinal Health; and AllCare. 

Grand View Research has segmented the global laparotomy sponges market on the basis of technology, end use, and region:

Laparotomy Sponges Technology Outlook (Revenue, USD Million, 2014 - 2025)

• Radiopaque
• Traditional
• RFID

Laparotomy Sponges End Use Outlook (Revenue, USD Million, 2014 - 2025)

• Hospitals
• Surgery centers

Laparotomy Sponges Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Mexico
  • Brazil
• Middle East & Africa
  • South Africa

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-laparotomy-sponge-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Microelectronic Medical Implants Market Is Estimated To Surpass Mark Of $57.12 Billion By 2025

The global Microelectronic Medical Implants Market size is anticipated to reach USD 57.12 billion by 2025, according to a new report by Grand View Research, Inc., registering a 9.8% CAGR during the forecast period. Increasing prevalence of cardiac disorders, epilepsy, and Parkinson’s disease, growing regulatory approvals for new devices and equipment, rising geriatric population, and introduction of new products are key factors driving market growth. 

Regulatory authorities such as U.S. FDA have approved several new products and devices to be used by end users, most of which are equipped with new and innovative technologies that cater to varied consumer demands. These technologies also increase the ease of use of these products. For instance, in July 2017, Cochlear Ltd. introduced to the market a cochlear implant sound processor for iPhone. The U.S. FDA approved this innovation in June 2017.

Increasing prevalence of diseases such as epilepsy, cardiac disorders, and Parkinson’s disease have upped the sales of microelectronic electronic implants such as defibrillators, pacemakers, and neurostimulators. As per WHO, approximately 50 million people have epilepsy, globally, making it one of the most common neurological disorders. The condition can be treated using neurostimulators that prevent seizures.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/microelectronic-medical-implants-market 

Further key findings from the study suggest:

• By product, the pacemakers and defibrillators segment accounted for the largest share in 2016 owing to increasing prevalence of cardiovascular diseases and rising geriatric population
• RF technology accounted for the largest share in 2016 as it is employed in wireless implants and helps researchers and clinicians monitor patient health, capture physiological data, and study normal and abnormal functioning of the body
• North America commanded the largest share in the microelectronic medical implants market in 2016 and is expected to maintain its position over the forecast period. This is owing to favorable government policies, increasing FDA approvals for various medical devices in U.S., and high incidence of cardiac diseases
• Key market players include Zimmer Biomet Holdings, Inc.; Cochlear Ltd.; Medtronic plc; Abbott Laboratories; Zoll Medical; Boston Scientific Corporation; LivaNova PLC; Biotronik; Schiller; and Koninklijke Philips N.V.

Grand View Research has segmented the global microelectronic medical implants market on the basis of product, technology, and region: 

Microelectronic Medical Implants Product Outlook (Revenue, USD Million, 2014 - 2025)

• Pacemakers & Defibrillators
• Neurostimulators
• Implantable Drug Pumps
• Spinal Fusion Stimulators
• Cochlear Implants
• Ocular Implants
• Others

Microelectronic Medical Implants Technology Outlook (Revenue, USD Million, 2014 - 2025)

• RF Technology
• Sensors
• Other Technology

Microelectronic Medical Implants Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-microelectronic-medical-implants-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Patient Engagement Solutions Market Revenue Would Be $39.3 Billion By 2024: Grand View Research, Inc.

The global Patient Engagement Solutions Market is expected to reach USD 39.3 billion by 2024, according to a new report by Grand View Research, Inc. The supportive government initiatives and the rising usage and awareness of mobile healthcare services are expected to impel the market growth.

The rising prevalence of chronic conditions is the preliminary factor that is expected to advance the market growth. The mortality rate of diabetic patients was over 1.0 million in 2012, as stated by the WHO. This hike in the death rate of diabetic patients reflects the lack of knowledge about the causes, symptoms, and the preventive measures of the disease. The present patient engagement systems aid in furnishing patients with educative information; thus, empowering them to make better healthcare decisions.

The patient engagement solutions cater to the hospitals in providing financial solutions for effective utilization of the allocated healthcare budget. Furthermore, the market players are actively volunteering in obtaining patient feedback regarding the existent solutions to develop better patient engagement plat forms with enhanced quality.

Moreover, the favorable government initiatives and the funding efforts undertaken to promote the incorporation of patient engagement solutions in the healthcare sector help in boosting the market growth. For instance, in the U.S., under the Health Information Technology for Economic and Clinical Health (HITECH) act, the government spends around USD 20 billion annually on hospitals for the installation of Electronic Health Records (EHRs), which is expected to help in improving the workflow and the quality of treatment delivery.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/patient-engagement-solutions-market

Further key findings from the study suggest:

• The web-based delivery segment is expected to be the largest delivery mode growing at a lucrative CAGR over the forecast period.
• North America is expected to dominate over the forecast period with a revenue share of over 40.0% in 2024. Favourable government initiatives, such as the Affordable Care Act (ACA) initiated by President Obama and the Health Information Technology for Economic and Clinical Health (HITECH) act, are anticipated to drive the market growth.
• Asia Pacific is anticipated to emerge as the fastest growing region with a CAGR of over 20.0% over the forecast period. The increasing investments in the healthcare sector, rising awareness with regard to the varying types of patient engagement portals, and the escalating geriatric population base are estimated to catapult the demand.
• Some key players of the market include Allscripts Healthcare Solutions, Inc., Cerner Corporation, Phytel, Inc., Athenahealth, Inc., McKesson Corporation, and MEDecision, Inc.
• In order to curtail the competition, the key industry players are actively involved in the development of new solutions that facilitate the workflow of the existing platforms. For instance, Allscripts Healthcare Solutions, Inc. provides revenue cycle management solutions, which help in maintaining the financial health of the medical systems.

Grand View Research has segmented the patient engagement solutions market on the basis of the type of delivery, component, end-use, application, therapeutic area, and region. 

Global Patient Engagement Solutions Market, Type of Delivery Outlook (Revenue, USD Million, 2013 - 2024)

• On-premise
• Cloud-based
• Web-based

Global Patient Engagement Solutions Market, Component Outlook (Revenue, USD Million, 2013 - 2024)

• Software
  • Standalone
  • Integrated
• Hardware
• Services
  • Consulting Services
  • Implementation Services
  • Education Services
  • Other Services

Global Patient Engagement Solutions Market, End-use Outlook (Revenue, USD Million, 2013 - 2024)

• Payers
• Providers
• Individual Users

Global Patient Engagement Solutions Market, Application Outlook (Revenue, USD Million, 2013 - 2024)

• Health Management
• Financial Health Management
• Social Management
• Home Healthcare Management

Global Patient Engagement Solutions Market, Therapeutic Area Outlook (Revenue, USD Million, 2013 - 2024)

• Chronic Diseases
  • Obesity
  • Diabetes
  • Cardiovascular Diseases
• Women’s Health
• Mental Health
• Fitness
• Others

Patient Engagement Solutions Market Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

Browse Full Press Release of This Report:  www.grandviewresearch.com/press-release/global-patient-engagement-solutions-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Blood Screening Market Size Is Set To Reach USD 3.9 Billion By 2024: Grand View Research, Inc.

The global Blood Screening Market is expected to reach a value of USD 3.9 billion by 2024, based on a new report by Grand View Research, Inc. The growth of the market is attributed to the increasing screening of donor and continuous technological advancements by the market players. Demand for blood screening tests are increasing continuously due to increasing donation, rising awareness about transfusion-transmitted diseases, and technological developments in the industry.

Thorough screening is necessary for all donated blood to ensure that recipients receive the safest products. As of 2015, such testing consists of screening for red cell antibodies, and the infectious diseases agents: HIV-1, HIV-2, hepatitis virus, West Nile Virus (WNV), Human T-Lymphotropic Virus (HTLV) T. Cruzi, and T. pallidum (syphilis). Result of all these assays must be negative for blood donation.

Technological developments in the market increase the sensitivity and efficiency of the tests. For instance, in 2016, the U.S. FDA approved the Procleix Zika virus assay from Hologic, Inc. and Grifols to screen donated blood. Furthermore, the U.S. FDA approved next-generation sequencing (NGS) technology in 2013. The technology is cheaper and faster than previous DNA analysis methods.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/blood-screening-market

Further Key Findings from the Study Suggest:

• Nucleic acid amplification test or nucleic acid test (NAT) is expected to be the fastest growing segment during the forecast period. It comprises transcription mediated amplification (TMA) tests and polymerase chain reaction. Increasing demand of NAT over ELISA test due to high sensitivity and specificity for viral nucleic acid is contributing to the fastest growth during the forecast period.
• In 2015, reagent dominated the product segment. Introduction of new assays for the detection of various diseases is expected to enable the segment to gain the maximum share of market in the coming years. For instance, in January 2015 the FDA approved Roche’s blood screening assay COBAS TaqScreen MPX Test for the detection and identification of HCV, HIV, and HBV. 
• In 2015, regionally North America dominated with a revenue share of more than 40%. Government initiatives, presence of major players, and more patient affordability are the major factors that contributed toward its dominance.
• In August 2016, the FDA recommended the testing of all the donated blood in the U.S. and its territories for Zika virus in order to prevent transmission of this virus through the blood supply.
• Asia Pacific is expected to be the fastest growing region due to increasing investment of industry players, government initiatives, and rising awareness about transmission of diseases during its transfusion.
• The Red Cross in Japan entered into a contract with Grifols for nucleic acid testing (NAT) for a blood donation camp in Japan in 2014. This agreement is anticipated to propel the NAT market during the forecast period. However, low donation as compared to requirement and high cost of kits and instruments are likely to restrain the growth in low-income countries during the forecast period.

Grand View Research has segmented the blood screening market by technology, product and region:

Blood Screening Market Technology Outlook (Market Revenue in USD Million, 2013 - 2024)

• Nucleic Acid Amplification Test (NAT)
• ELISA
• Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
• Next-Generation Sequencing (NGS)
• Western Blotting

Blood Screening Market Product Outlook (Market Revenue in USD Million, 2013 - 2024) 

• Reagent
• Instrument

Blood Screening Market Regional Outlook (Market Revenue in USD Million, 2013 - 2024)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
• Middle East and Africa
  • South Africa

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-blood-screening-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Breath Analyzer Market Size Is To Be $11.3 Billion By 2024: Grand View Research, Inc.

The global Breath Analyzer Market is expected to reach USD 11.3 billion by 2024, according to a new report by Grand View Research, Inc. Major drivers of the market include the demand for breath analyzers arising from the law enforcement agencies as well as other institutions, such as schools, sports, and offices, to minimize alcohol abuse and ensure safety in workplace settings. 

The fuel cell technology has been widely used in professional breath analyzers as it offers accuracy, alcohol specificity, and portability. Moreover, the semiconductor sensor technology offers affordable breath alcohol screening devices that are mostly used by private consumers. Breath analyzers that use infrared spectroscopy are currently limited to the law enforcement agencies owing to their high cost and large device size. 

The growing demand for quick and easy methods for the primary diagnosis of diseases, such as asthma, chronic obstructive pulmonary disease, and cancer is augmenting the growth of the global market. In addition, the rising adoption of breath analyzers in smoking cessation programs to detect carbon monoxide in the exhaled air is augmenting the market growth. 

Uncertainty with regard to the accuracy of the devices, the ambiguous laws about installing these devices in offices, and the high prices attached to infrared spectroscopy are the factors that challenge the growth of the global market. Many of the drug detection devices that identify the presence of drugs in the exhaled breath are still in the developmental phase as the detection technology used will depend on the type of the drug. Hence, this poses some uncertainty for the success of these devices. 

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/breath-analyzer-market

Further key findings from the study suggest:

• In 2015, the fuel cell technology segment accounted for the largest share of the market at31.8%. The dominance of the segment is attributed to the popularity of this technology owing to its accuracy and user-friendly product designs.
• The medical application segment is expected to witness the fastest growth from 2016 to 2024 owing to the rapid development of disease diagnostics, such as breath analyzers for asthma and Chronic Obstructive Pulmonary Diseases (COPD)
• North America captured the largest market share at over half of the total revenue in 2015 and is expected to maintain its dominance throughout the forecast period. The presence of a large number of major market players, strict laws for road traffic safety, and a high adoption rate of the advanced technologies are the factors driving the market growth in this region.
• The Asia Pacific market is expected to grow at a lucrative CAGR of around 32% during the forecast period. The existence of a large untapped market and the growing awareness regarding the commercially available and technically advanced products are some of the major drivers of the market in the region.
• The presence of a large number of local manufacturers in the Asia Pacific region offering low-cost breath analyzers in comparison to other manufacturers based in developed countries is one of the factors expected to propel the exports from this region
• Some key players in the Breath Analyzer Market include Dragerwerk AG & Co. KGaA, Intoximeter, Inc., Alcovisor, Quest products, Inc., Lifeloc Technologies, Akers Biosciences, Inc., MPD, Inc., AK GlobalTech Corp., Alcohol Countermeasure Systems Corp., and EnviteC-Wismar GmbH 

Grand View Research has segmented the Breath Analyzer Market on the basis of product, type, and geography.

Breath Analyzer Market, by Technology, 2013 - 2024 (USD Million)

• Fuel cell Technology
• Semiconductor sensor
• Infrared (IR) Spectroscopy
• Others(FAIM, Mass Spectroscopy, Smart Crystals)

Breath Analyzer Market, by Application, 2013 - 2024 (USD Million)

• Drug Abuse Detection
• Alcohol Detection
• Medical Applications

Breath Analyzer Market, by region, 2013 - 2024 (USD Million)

• North America
  • US. Breath Analyzer Market, by Technology Type
  • US. Breath Analyzer Market, by Application Type
  • Canada Breath Analyzer Market, by Technology Type
  • Canada Breath Analyzer Market, by Application Type
• Europe
  • UK Breath Analyzer Market, by Technology Type
  • UK Breath Analyzer Market, by Application Type
  • Germany Breath Analyzer Market, by Technology Type
  • Germany Breath Analyzer Market, by Application Type 
• Asia Pacific
  • China Breath Analyzer Market, by Technology Type
  • China Breath Analyzer Market, by Application Type
  • India Breath Analyzer Market, by Technology Type
  • India Breath Analyzer Market, by Application Type
• Latin America
  • Brazil Breath Analyzer Market, by Technology Type
  • Brazil Breath Analyzer Market, by Application Type
  • Mexico Breath Analyzer Market, by Technology Type
  • Mexico Breath Analyzer Market, by Application Type
• MEA
  • South Africa Breath Analyzer Market, by Technology Type
  • South Africa Breath Analyzer Market, by Application Type

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-breath-analyzer-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Structural Core Materials Market Size Is Going To Surpass $2.80 Billion By 2025: Grand View Research, Inc.

The global Structural Core Materials Market size is expected to reach USD 2.80 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 5.9% during the forecast period. As the wind energy sector continues to flourish, structural core materials are anticipated to rake in a healthy share in the revenue pie. Rising consumer disposable income of people in countries such as U.S., India, and China is leading to expansion of the aerospace and automotive industries, thereby boosting the need for structural core materials for parts and components manufacturing. 

In terms of revenue, aerospace was the largest end-use segment, accounting for about 38.0% of the global market in 2016. In the field of aircraft and helicopter engineering, sandwich structures are the preferred choice for lightweight yet high-strength designs. High temperature resistance of cores has further facilitated the demand for these products.

Booming aerospace and construction industries worldwide are unfolding several growth opportunities for the structural core materials market. However, prices of raw materials used for manufacturing could play a crucial role in overall production cost in the future.

DIAB International AB, a major player in the market, tripled its production capacity of advanced foam cores to meet increasing demand from the aerospace industry worldwide. A few companies acquired and merged with each other to enhance their product offerings and expand their global reach. For instance, Gurit Holding AG acquired BASF’s PET structural foam business with the intention of strengthening Gurit’s range of structural core material products. Such strategic initiatives reflect the intensifying competition in the structural core materials market.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/structural-core-materials-market

Further key findings from the report suggest:

• The wind energy end-use segment is slated to experience the fastest growth in terms of revenue, progressing at a CAGR of 8.4% from 2017 to 2025. The growth of the segment can be attributed to increasing number of wind farms in emerging economies
• Carbon FRP emerged as the largest skin type segment in terms of revenue in 2016 and is projected to value more than USD 1.15 billion by 2025. The segment is poised to experience steady growth over the forecast period owing to superior properties offered by carbon fiber-based materials in lightweight and high-strength construction
• The Asia Pacific region is likely to register the highest CAGR over the forecast years owing to rapid growth of the aerospace, automotive, and wind energy industries in the region, most notably in India and China. In terms of revenue, the regional market is expected to post a CAGR of 7.6% from 2017 to 2025
• Players such as Rockwell Collins, Inc.; DIAB International AB; Evonik Industries; Gurit Holding AG; Schweiter Technologies; Hexcel Corporation; and The Gill Corporation dominated the global structure core materials market.

Grand View Research has segmented the global structural core materials market on the basis of product, skin type, end use, and region:

Structural Core Materials Product Outlook (Volume, Kilotons; Revenue, USD Million, 2014 - 2025)

• Foam
• Balsa
• Honeycomb

Structural Core Materials Skin Type Outlook (Volume, Kilotons; Revenue, USD Million, 2014 - 2025)

• GFRP
• CFRP
• NFRP
• Others

Structural Core Materials End Use Outlook (Volume, Kilotons; Revenue, USD Million, 2014 - 2025)

• Aerospace
• Automotive
• Wind energy
• Marine
• Construction
• Others

Structural Core Materials Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2014 - 2025)

• North America
  • US.
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
  • Brazil
• Middle East & Africa
  • Saudi Arabia

Access Press Release of this Report: www.grandviewresearch.com/press-release/global-structural-core-materials-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

3D Printing Metal Market Is Predicted To Outshine $2.86 Billion By 2025: Grand View Research, Inc.

The global 3D printing metals market is expected to reach USD 2.86 billion by 2025, according to a new report by Grand View Research, Inc. Metals are the fastest growing 3D printing materials worldwide on account of high application scope coupled with increasing demand from the medical and dental application.

The market has witnessed advancements, both in terms of technologies and materials, in order to facilitate low cost and mass production of the products. This would also lead to flexibility in designs and ease of manufacturing of products for wide range of applications.

Numerous companies including GE have been utilizing metal 3D printing for the development of aerospace parts. In December 2016, Sigma Labs entered into a new contract with Honeywell aerospace. The Defense Advanced Research Project Agency (DARPA) selected the company for completion of phase III of the Open Manufacturing (OM) program. It is aimed at reducing the barriers involved in the metal 3D printing process including speed, cost, and repeatability.

Browse Full Research Report on 3D Printing Metals Market: www.grandviewresearch.com/industry-analysis/3d-metal-printing-market

Further key findings from the report suggest:

• Powder segment is expected to witness the fastest CAGR of over 30% from 2016 to 2025 on account of significant technological development in the field of metal printers
• Aerospace & defense sector dominated the industry in 2015 with a share of over 35% and is anticipated to witness significant growth on account of high application scope in military aircraft, aircraft engine, commercial aircraft, complex weapon systems, high volume weapons, and munition components
• The medical sector accounted for a share of over 30%, in terms of revenue, in 2015 on account of increasing use of the technology in medical implants, medical devices, and surgical equipment including crowns & bridges, model castings, and abutments
• Titanium is expected to witness rapid growth from 2016 to 2025 on account of superior mechanical properties, accuracy in production, and early adoption of the product in aerospace & defense and medical industry
• Asia Pacific is anticipated to witness the fastest growth of over 30% from 2016 to 2025 on account of rapid industrial development, supportive government policies, and high R&D investment in China, Japan, and South Korea
• New product development is one of the major strategies being adopted by the industry players in order to strengthen their global position

Read Our Blog: www.grandviewresearch.com/blogs/bulk-chemicals

Grand View Research has segmented the global 3D printing metals market on the basis of form, product, application, and region:

Form Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• Powder
• Filament

Product Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• Titanium
• Nickel
• Steel
• Aluminum
• Others

Application Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• Aerospace & Defense
• Automotive
• Medical & Dental
• Others

Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• North America
  • US.
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • Japan
• Central & South America
  • Brazil
• Middle East & Africa 

Access Press Release of this Report: www.grandviewresearch.com/press-release/global-3d-metal-printing-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

U.S. Beer & Cider Market Revenue Would Be $271.12 Billion by 2025 | CAGR: 11.6%: Grand View Research, Inc.

The U.S. Beer & Cider Market size is estimated to attain USD 271.12 billion by 2025, growing at a CAGR 11.6%, according to a new study by Grand View Research, Inc. The growing private breweries in the country is expected to stimulate the market growth over the next eight years.

States such as Maine, Colorado, and Michigan are among the popular craft beer producing states. The market is expected to witness robust growth due to large presence of microbrewery, brewpub, and contract brewing companies among others in the country. Furthermore, supportive government regulations in some states is anticipated to encourage the market growth.

The volume of beer & cider consumption is expected to grow at a low pace, owing to the growing increasing millennial generation shifting towards becoming more health conscious. Moreover, consumers that attain legal drinking age are lesser prone to consuming alcohol that is presumed to reduce beer and cider consumption.

The presence of a large number of beer and cider products makes the market more competitive. Furthermore, the market participants are using different combinations of raw materials to develop various types of beer & cider products such as Larger, Ale, and Pilsner among others.

The industry players comprise mainly big players that have large market share and are mainly focused on retaining their market share. Furthermore, these companies have a multi-regional presence and witness stiff competition. The companies have various brands of beer that are developed particularly for each region.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/us-beer-cider-market 

Further key findings from the study suggest:

• The beer and cider market in the U.S. contributed around 67.8 billion to the country’s economy and has provided over 456,000 full-time jobs
• Beer is the fastest-growing segment, registering a CAGR of 11.7% over the next years. The growth is attributed to growing establishment of breweries in the country
• Regulations across states stipulate that breweries have produce certain amount of beer (in gallons) for commencement of operations. The amount varies with the states
• The industry mainly employs three stage distribution (including producers, wholesalers, and retailers) of beer & cider products
• Highest beer consuming states in 2015 include North Dakota, New Hampshire, Montana, South Dakota, and Vermont among others

Grand View Research has segmented the U.S. beer & cider market based on product:

U.S. Beer & Cider Product Scope (Revenue, USD Billion; Volume, Billion Units; 2014 - 2025)

• Beer
• Cider

Browse Press Release of this Report: www.grandviewresearch.com/press-release/us-beer-cider-market-analysis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Drill Pipes Market Is Estimated To Generate $1.31 Billion By 2025: Grand View Research, Inc.

The global Drill Pipes Market is expected to reach USD 1.31 billion by 2025, according to a new report by Grand View Research, Inc. Increasing innovation regarding improving product strength is a major trend in the industry. Industry players are focused on developing new technologies and raw materials for better performance in all type of drilling conditions including onshore and offshore remote oil and gas fields.

However, the dip in the crude oil prices over the last two years has restricted the market growth. Rig rental capital is declining in the offshore market, and customers have significantly higher bargaining power in negotiating new contracts and extensions, leading to lower day rates and an oversupply of rigs. 

API grade drill pipes held the largest share in global demand and are expected to continue their dominance over the forecast period. Standardization of the finished products along with the relatively low prices of this grade are anticipated to promote market penetration. Utilizing these products also ensure reduced operational cost to the E&P and operator companies.

API grade products are mostly preferred in normal environments and conventional basins owing to the easy availability and reduced OpEx to both E&P and contractor companies. Exploration in unconventional and harsh environmental conditions particularly in shale, CBM, and tight reserves are expected to steer premium grade drill pipes demand over the forecast period. 

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/drill-pipe-market 

Further key findings from the report suggest:

• Premium grade drill pipes are expected to account for over 25% of the revenue by 2025. The increasing use of premium grade in tight oil and gas formation is anticipated to drive the segment growth over the next eight years.
• Onshore fields dominated the global drill pipe market with a net demand of over USD 580 million in 2015. Hike in E&P in shale and CBM fields particularly in the U.S., Canada, and China have been the key factors responsible for high market penetration.
• The U.S. market demand in offshore basins exceeded a net value of USD 64 million in 2015 and is estimated to grow at a CAGR of 4.3% from 2016 to 2025
• Asia Pacific is anticipated to witness the fastest growth over the forecast period owing to the flexible regulatory scenario in economies including India, China, Indonesia, and Singapore. The Indonesian drill pipe industry is anticipated to reach a net value exceeding USD 19 million by 2025.
• The global market is dominated mostly by regional players. Some of the multinational players include Inter Drill Asia, TPS TECHNITUBE RÖHRENWERKE, Vallourec, and National Oilwell Varco.

Grand View Research has segmented the global drill pipes market on the basis of grade, application and region:

Global Drill Pipes Grade Outlook (Revenue, USD Million, 2014 - 2025)  

• API Grade
• Premium Grade

Global Drill Pipes Application Outlook (Revenue, USD Million, 2014 - 2025)

• Onshore
• Offshore

Global Drill Pipes Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Russia
  • UK
  • Norway
• Asia Pacific
  • China
  • India
  • Indonesia
• Central & South America
  • Brazil
  • Argentina
  • Venezuela
• Middle East
  • Saudi Arabia
  • UAE
  • Qatar
  • Kuwait
• Africa

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-drill-pipe-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com